Change in aqueous cytokine level after intravitreal anti-VEGF therapy in diabetic macular edema

Change in aqueous cytokine level after intravitreal anti-VEGF therapy in diabetic macular edema - the effect of anti-VEGF therapy on aqueous cytokine level in DME

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044771

Enrollment

Registered

2021-07-06

Start date

2021-01-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic macular edema

Interventions

aqueous humor collection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: DME patients who receive anti VEGF agent.

Exclusion criteria

Exclusion criteria: treatment history (surgery or photocoagulation) in 3 months. allergy pregnant participating any other study

Design outcomes

Primary

Measure	Time frame
the change in aqueous cytokine level	—

Countries

Japan

Contacts

Public Contactmasakazu morioka

Fukui University Ophthalmology

mmorioka@u-fukui.ac.jp0776613111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026